{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "18655281", "DateCompleted": {"Year": "2008", "Month": "09", "Day": "10"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["rus"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0042-8787", "JournalIssue": {"Issue": "3", "PubDate": {"Year": "2008", "Season": "May-Jun"}}, "Title": "Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury", "ISOAbbreviation": "Vopr Kurortol Fizioter Lech Fiz Kult"}, "ArticleTitle": "[Combined treatment including ozonotherapy of patients with viral hepatitis ].", "Pagination": {"StartPage": "19", "EndPage": "22", "MedlinePgn": "19-22"}, "Abstract": {"AbstractText": ["Patients with viral hepatitis have disturbances of biliary tract motor function with the tendency to hypertonus of Oddi's sphincter, changes of physic-colloid properties of bile with increase in density of gall and hepatic bile, pH shift to acid side, microlites formation, disorders in biochemical composition of bile. More than 80% patients have biliar insufficiency. According to our data, with the purpose to correct of disturbances of hepatic exocrine function in patients with viral hepatitis and to prevent stone formation, it is reasonable to use together with antiviral therapy also intravenous injection of ozonated physiological solution and preparations of ursodeoxycholic acid."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Chernyshev", "ForeName": "A L", "Initials": "AL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Filimonov", "ForeName": "R M", "Initials": "RM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Karasev", "ForeName": "A V", "Initials": "AV"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Neronov", "ForeName": "V A", "Initials": "VA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Maksimov", "ForeName": "V A", "Initials": "VA"}], "PublicationTypeList": ["English Abstract", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Russia (Federation)", "MedlineTA": "Vopr Kurortol Fizioter Lech Fiz Kult", "NlmUniqueID": "2984868R", "ISSNLinking": "0042-8787"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["chemistry"], "DescriptorName": "Bile"}, {"QualifierName": [], "DescriptorName": "Combined Modality Therapy"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["physiopathology", "therapy"], "DescriptorName": "Hepatitis B"}, {"QualifierName": ["physiopathology", "therapy"], "DescriptorName": "Hepatitis B, Chronic"}, {"QualifierName": ["physiopathology", "therapy"], "DescriptorName": "Hepatitis C"}, {"QualifierName": ["physiopathology", "therapy"], "DescriptorName": "Hepatitis C, Chronic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2008", "Month": "7", "Day": "26", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "9", "Day": "11", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "7", "Day": "26", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18655281"]}}], "PubmedBookArticle": []}